Seagen Logo +
Seagen EVP Commercial - Charles (Chip) Romp

Charles (Chip) Romp

Executive Vice President, Commercial

In it to foster a culture that is true to our patient-centric values. 

Chip leads our U.S. and Canadian commercial organizations and has over 27 years of biotechnology and pharmaceutical experience. Since joining Seagen to build our original ADCETRIS sales team, he has consistently provided decisive leadership and clear direction, and fostered a team culture that is true to our patient-centric values. Chip has continued to deliver strong results with the expansion of our portfolio to three brands: ADCETRIS® (brentuximab vedotin), PADCEV® (enfortumab vedotin-ejfv), and TUKYSA® (tucatinib). 

Previously, Chip was a National Sales Director for oncology and immunology products at Genentech, including Avastin® (bevacizumab) and Rituxan® (rituximab). While at Genentech, he also led deployment of the BioOncology sales forces. Earlier in his career, Chip was a Product Manager at GE Medical Systems and a pharmaceutical sales representative at Sankyo Park Davis and GlaxoSmithKline. 

Chip holds an M.B.A. from Saint Leo University (formerly Saint Leo College) and a B.A. from the University of Florida.  


RECENT MENTIONS